TumCP Cancer Research Results
TumCP, Tumor Cell proliferation: Click to Expand ⟱
| Source: |
| Type: |
Tumor cell proliferation is a key characteristic of cancer. It refers to the rapid and uncontrolled growth of cells that can lead to the formation of tumors.
|
Scientific Papers found: Click to Expand⟱
TumCP∅, After testing E8 cell line singly with FBZ then VES, we determined that neither FBZ at 22.5 ng/ml nor VES at 25 μg/ml had any significant inhibitory effect on proliferation, at least during the four days of exposure
TumCP↓, However, when we used a lower concentration of FBZ (14 ng/ml) together with VES (25 μg/ml), beginning at the third day, a synergistic inhibitory effect on proliferation was observed that became robust in the subsequent days
toxicity↓, FBZ, VES, or a VES+FBZ combination administered in the feed for 206 days at which point they were humanely euthanized ... no abnormalities were observed
eff↑, In summary, combination therapy with VES and FBZ deserves further investigation as a possible treatment modality for prostate cancer
| - |
in-vitro, |
BC, |
MDA-MB-231 |
|
|
|
- |
in-vitro, |
BC, |
MCF7 |
|
|
|
- |
in-vitro, |
BC, |
T47D |
|
|
|
eff↝, Its pharmacological effects in vivo may be either estrogenic or anti-estrogenic, mainly depending upon the estrogen levels.
TumCP↓, formononetin inhibited the proliferation of ER-positive MCF-7 cells and T47D cells.
TumCP∅, In contrast, formononetin could not inhibit the cell of growth of ER-negative breast cancer cells such as MDA-MB-435 S cells.
MAPK↑, formononetin activated MAPK signaling pathway in a dose-dependent manner, which resulted in the increased ratio of Bax/Bcl-2, and induced apoptosis on MCF-7 cells.
Bax:Bcl2↑,
Apoptosis↑,
TumCP∅, All of these suggested that isoquercetin could not inhibit the proliferation of bladder cancer EJ cells.
NA∅, isoquercetin did not inhibit the STAT3 signal pathway of bladder cancer EJ cells, which may be one of the reasons that cause the tolerance of EJ cells to isoquercetin
Ca+2↑, After exposure to electromagnetic fields the basal [Ca(2+)](i) levels increased significantly from 143 +/- 46 nM to 278 +/- 125 nM
TumCP∅, Moreover the electromagnetic fields that affected [Ca(2+)](i) did not cause cell proliferation or cell death and the proliferation indexes remained unchanged after exposure.
TumCD∅,
eff↑, However, the [Ca 2+]i levels in normal and caffeine-treated cells were signicantly higher after EMF exposure than in sham exposed cells
exposed cells
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Liver, |
HepG2 |
|
|
|
- |
in-vitro, |
CRC, |
HCT116 |
|
|
|
T-Cell↑,
TumCP∅, SMP showed no effect on the proliferation of the tumor cells
IL4↑,
IL6↑,
IFN-γ↑,
TLR4↑,
TLR1↑,
TLR2↑,
p‑JNK↑,
p‑ERK↑,
IKKα↑,
Showing Research Papers: 1 to 5 of 5
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
NA∅, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 1, Bax:Bcl2↑, 1, p‑JNK↑, 1, MAPK↑, 1, TumCD∅, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
p‑ERK↑, 1,
Migration(tgid=13) ⓘ
Ca+2↑, 1, TumCP↓, 2, TumCP∅, 5,
Immune & Inflammatory Signaling(tgid=16) ⓘ
IFN-γ↑, 1, IKKα↑, 1, IL4↑, 1, IL6↑, 1, T-Cell↑, 1, TLR1↑, 1, TLR2↑, 1, TLR4↑, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
eff↑, 2, eff↝, 1,
Clinical Biomarkers(tgid=22) ⓘ
IL6↑, 1,
Functional Outcomes(tgid=23) ⓘ
toxicity↓, 1,
Total Targets: 22
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: TumCP, Tumor Cell proliferation
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:% prod#:% Target#:327 State#:% Dir#:6
wNotes=on sortOrder:rid,rpid
Home Page